A detailed history of Klingenstein Fields & CO LP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 75,920 shares of TMO stock, worth $43.1 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
75,920
Previous 76,315 0.52%
Holding current value
$43.1 Million
Previous $47.2 Million 16.33%
% of portfolio
1.61%
Previous 1.9%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

SELL
$501.29 - $612.85 $198,009 - $242,075
-395 Reduced 0.52%
75,920 $39.5 Million
Q3 2024

Oct 29, 2024

BUY
$531.86 - $624.21 $71,801 - $84,268
135 Added 0.18%
76,315 $47.2 Million
Q2 2024

Aug 01, 2024

SELL
$541.52 - $599.02 $1.13 Million - $1.25 Million
-2,094 Reduced 2.68%
76,180 $42.1 Million
Q1 2024

Apr 29, 2024

SELL
$528.82 - $599.43 $966,682 - $1.1 Million
-1,828 Reduced 2.28%
78,274 $45.5 Million
Q4 2023

Feb 01, 2024

SELL
$431.41 - $532.94 $882,664 - $1.09 Million
-2,046 Reduced 2.49%
80,102 $42.5 Million
Q3 2023

Oct 27, 2023

SELL
$498.29 - $574.41 $53,317 - $61,461
-107 Reduced 0.13%
82,148 $41.6 Million
Q2 2023

Aug 01, 2023

SELL
$508.46 - $591.13 $392,022 - $455,761
-771 Reduced 0.93%
82,255 $42.9 Million
Q1 2023

Apr 28, 2023

SELL
$535.0 - $604.82 $574,055 - $648,971
-1,073 Reduced 1.28%
83,026 $47.9 Million
Q4 2022

Feb 02, 2023

SELL
$484.71 - $571.37 $911,254 - $1.07 Million
-1,880 Reduced 2.19%
84,099 $46.3 Million
Q3 2022

Oct 28, 2022

SELL
$507.19 - $604.49 $466,107 - $555,526
-919 Reduced 1.06%
85,979 $43.6 Million
Q2 2022

Aug 01, 2022

BUY
$500.9 - $612.21 $292,024 - $356,918
583 Added 0.68%
86,898 $47.2 Million
Q1 2022

Apr 27, 2022

SELL
$524.0 - $644.92 $94,320 - $116,085
-180 Reduced 0.21%
86,315 $51 Million
Q4 2021

Jan 31, 2022

SELL
$569.0 - $667.24 $735,717 - $862,741
-1,293 Reduced 1.47%
86,495 $57.7 Million
Q3 2021

Oct 26, 2021

SELL
$509.53 - $609.78 $486,091 - $581,730
-954 Reduced 1.08%
87,788 $50.2 Million
Q2 2021

Jul 26, 2021

SELL
$441.0 - $508.24 $1,323 - $1,524
-3 Reduced -0.0%
88,742 $44.8 Million
Q1 2021

Apr 29, 2021

SELL
$439.85 - $518.83 $1.35 Million - $1.59 Million
-3,064 Reduced 3.34%
88,745 $40.5 Million
Q4 2020

Feb 02, 2021

SELL
$435.06 - $527.66 $708,712 - $859,558
-1,629 Reduced 1.74%
91,809 $42.8 Million
Q3 2020

Oct 30, 2020

SELL
$359.77 - $441.52 $894,388 - $1.1 Million
-2,486 Reduced 2.59%
93,438 $41.3 Million
Q2 2020

Aug 03, 2020

SELL
$275.2 - $362.34 $26,969 - $35,509
-98 Reduced 0.1%
95,924 $34.8 Million
Q1 2020

May 07, 2020

SELL
$255.3 - $340.05 $30,891 - $41,146
-121 Reduced 0.13%
96,022 $27.2 Million
Q4 2019

Feb 04, 2020

SELL
$271.93 - $328.04 $726,868 - $876,850
-2,673 Reduced 2.71%
96,143 $31.2 Million
Q3 2019

Nov 01, 2019

SELL
$268.46 - $305.43 $522,691 - $594,672
-1,947 Reduced 1.93%
98,816 $28.8 Million
Q2 2019

Aug 12, 2019

SELL
$257.51 - $295.55 $189,012 - $216,933
-734 Reduced 0.72%
100,763 $29.6 Million
Q1 2019

Apr 29, 2019

SELL
$212.17 - $273.72 $8.38 Million - $10.8 Million
-39,474 Reduced 28.0%
101,497 $27.8 Million
Q4 2018

Jan 22, 2019

SELL
$208.47 - $251.98 $438,412 - $529,913
-2,103 Reduced 1.47%
140,971 $31.5 Million
Q3 2018

Nov 01, 2018

SELL
$205.57 - $244.32 $732,857 - $871,000
-3,565 Reduced 2.43%
143,074 $34.9 Million
Q2 2018

Jul 26, 2018

BUY
$203.14 - $219.53 $60,129 - $64,980
296 Added 0.2%
146,639 $30.4 Million
Q1 2018

May 01, 2018

BUY
$192.98 - $224.11 $62,332 - $72,387
323 Added 0.22%
146,343 $30.2 Million
Q4 2017

Jan 30, 2018

SELL
$182.03 - $200.37 $181,119 - $199,368
-995 Reduced 0.68%
146,020 $27.7 Million
Q3 2017

Nov 01, 2017

BUY
$171.74 - $194.04 $25.2 Million - $28.5 Million
147,015
147,015 $27.8 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $223B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Klingenstein Fields & CO LP Portfolio

Follow Klingenstein Fields & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.